Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.

A Odén, L G Kindblom, L Angervall, C Merck, Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta pathologica, microbiologica, et immunologica Scandinavica. Supplement. ,vol. 282, pp. 1- 40 ,(1983)

JA Bridge, Christopher Fletcher, Fredrik Mertens, Pcw Hogendoorn, WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, vol. 5 World Health Organization. ,(2013)

Shintaro Iwata, Tsukasa Yonemoto, Akinobu Araki, Dai Ikebe, Hiroto Kamoda, Yoko Hagiwara, Takeshi Ishii, Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma. Journal of Surgical Oncology. ,vol. 110, pp. 707- 711 ,(2014) , 10.1002/JSO.23708

David B. Pearlstone, Peter W. T. Pisters, Richard J. Bold, Barry W. Feig, Kelly K. Hunt, Alan W. Yasko, Shreyaskumar Patel, Alan Pollack, Robert S. Benjamin, Raphael E. Pollock, Patterns of recurrence in extremity liposarcoma: Implications for staging and follow-up Cancer. ,vol. 85, pp. 85- 92 ,(1999) , 10.1002/(SICI)1097-0142(19990101)85:1<85::AID-CNCR12>3.0.CO;2-A

F Mitelman, I Panagopoulos, P Aman, N Mandahl, Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21). Oncogene. ,vol. 11, pp. 1133- 1137 ,(1995)

Helen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, Benedikt Brors, Carina Heydt, Michaela Angelika Ihle, Gunhild Mechtersheimer, Eva Wardelmann, Reinhard Büttner, Sabine Merkelbach-Bruse, FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro Oncotarget. ,vol. 6, pp. 20215- 20230 ,(2015) , 10.18632/ONCOTARGET.4046

Robert W. Mutter, Samuel Singer, Zhigang Zhang, Murray F. Brennan, Kaled M. Alektiar, The enigma of myxofibrosarcoma of the extremity Cancer. ,vol. 118, pp. 518- 527 ,(2012) , 10.1002/CNCR.26296

Amanda Capes-Davis, Yvonne A. Reid, Margaret C. Kline, Douglas R. Storts, Ethan Strauss, Wilhelm G. Dirks, Hans G. Drexler, Roderick A.F. MacLeod, Gregory Sykes, Arihiro Kohara, Yukio Nakamura, Eugene Elmore, Raymond W. Nims, Christine Alston-Roberts, Rita Barallon, Georgyi V. Los, Roland M. Nardone, Paul J. Price, Anton Steuer, Jim Thomson, John R.W. Masters, Liz Kerrigan, Match criteria for human cell line authentication: where do we draw the line? International Journal of Cancer. ,vol. 132, pp. 2510- 2519 ,(2013) , 10.1002/IJC.27931

Scott M. Wilhelm, Jacques Dumas, Lila Adnane, Mark Lynch, Christopher A. Carter, Gunnar Schütz, Karl-Heinz Thierauch, Dieter Zopf, Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity International Journal of Cancer. ,vol. 129, pp. 245- 255 ,(2011) , 10.1002/IJC.25864

Arend H. Sikkema, Sander H. Diks, Wilfred F.A. den Dunnen, Arja ter Elst, Frank J.G. Scherpen, Eelco W. Hoving, Rob Ruijtenbeek, Piet J. Boender, Rik de Wijn, Willem A. Kamps, Maikel P. Peppelenbosch, Eveline S.J.M. de Bont, Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery Cancer Research. ,vol. 69, pp. 5987- 5995 ,(2009) , 10.1158/0008-5472.CAN-08-3660